Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies
Quinn, Dean, Barnes, Christopher N., Yates, Wayne, Bourdet, David L., Moran, Edmund J., Potgieter, Peter, Nicholls, Andrew, Haumann, Brett, Singh, DaveLanguage:
english
Journal:
Pulmonary Pharmacology & Therapeutics
DOI:
10.1016/j.pupt.2017.10.003
Date:
October, 2017
File:
PDF, 1.20 MB
english, 2017